The durations, doses, and populations differ, and cagrilintides largest figures are combination (CagriSema) results, not standalone data
In December 2025, oral semaglutide was approved by the U.S
Primary care-based investigation of the effect of sitagliptin on blood pressure in hypertensive patients with type 2 diabetes
But in such a new field of research, customers of these weight-loss startups are essentially test subjects, says Chastain: "The danger to consumers is that they take on risk and expensive medication based on a claim that is not scientifically basedthat's not evidence-based." Startups, by nature, exist to fix problems
Pharmaceutical brands like Ozempic and Wegovy are FDA-approved versions of semaglutide, manufactured by Novo Nordisk
One multi-site health system reported that after ePA rollout, more patients were able to fill their GLP-1 prescriptions on the same day as the visit, rather than returning a week later with an approval letter